A carregar...
The Efficacy of Convalescent Plasma Use in Critically Ill COVID-19 Patients
Background and Objectives: On 24 March 2020, the United States Food and Drug Administration (FDA) announced the approval of convalescent plasma therapy for critically ill patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) as an emergency investigational new drug. This pilot s...
Na minha lista:
| Publicado no: | Medicina (Kaunas) |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7998120/ https://ncbi.nlm.nih.gov/pubmed/33799535 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/medicina57030257 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|